Genus Lifesciences Inc.
22 drugs in NADAC|19 Generic,3 Brand
View Recalls (1)Genus Lifesciences Inc. lists 22 NDCs in the CMS NADAC file (19 generic, 3 brand), at an average NADAC of $1.52 per unit, with a week-over-week move of -0.8% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.
Total Drugs
22
19G / 3B
Avg Price / Unit
$1.5216
$0.04 – $6.35
Avg 7d Change
-0.85%
Across 16 drugs with changes
7d Activity
of 22 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Hydrocodone Bitartrate and Homatropine Methylbromide market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Opioid Agonist therapeutic class
Review the broader class where Genus Lifesciences Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Genus Lifesciences Inc. make?
Genus Lifesciences Inc. lists 22 NDCs in the CMS NADAC file — 19 generic and 3 brand products.
What is the average price of Genus Lifesciences Inc. drugs?
The average NADAC across Genus Lifesciences Inc.'s portfolio is $1.5216 per unit, ranging from $0.0409 to $6.3519.
What types of drugs does Genus Lifesciences Inc. make?
Genus Lifesciences Inc. makes drugs across 10 FDA pharmacologic classes. The most common by NDC count are Opioid Agonist (10), Antimycobacterial (3), Histamine-1 Receptor Antagonist (2), Fluoroquinolone Antibacterial (1), Nonsteroidal Anti-inflammatory Drug (1).
Has Genus Lifesciences Inc. had any drug recalls?
1 FDA recall is matched to Genus Lifesciences Inc. in the openFDA feed, most recently on Dec 23, 2020.
How has Genus Lifesciences Inc.'s pricing changed recently?
Over the past 7 days, 3 Genus Lifesciences Inc. products rose and 13 fell, with a portfolio-wide average change of -0.8%.
FDA Recalls (1)
Recalls matched by company name. Verify current status with FDA.
Oxycodone Hydrochloride Oral Solution, USP 5 mg/5mL unit dose cups, Rx Only, Genus Lifesciences Inc. NDC 64950-354-05 Case NDC: 64950-354-450(40 unit dose cups) Case NDC 64950-354-55 (50 unit dose cups)
Presence of Foreign Substance: Particulate matter was found in multiple lots of product.